192 related articles for article (PubMed ID: 34684779)
1. Reconstitution of Caveolin-1 into Artificial Lipid Membrane: Characterization by Transmission Electron Microscopy and Solid-State Nuclear Magnetic Resonance.
Zhang Y; Zhang X; Kong W; Wang S
Molecules; 2021 Oct; 26(20):. PubMed ID: 34684779
[TBL] [Abstract][Full Text] [Related]
2. Structural and dynamic properties of juxta-membrane segments of caveolin-1 and caveolin-2 at the membrane interface.
Le Lan C; Gallay J; Vincent M; Neumann JM; de Foresta B; Jamin N
Eur Biophys J; 2010 Jan; 39(2):307-25. PubMed ID: 19847421
[TBL] [Abstract][Full Text] [Related]
3. Molecular Characterization of Caveolin-induced Membrane Curvature.
Ariotti N; Rae J; Leneva N; Ferguson C; Loo D; Okano S; Hill MM; Walser P; Collins BM; Parton RG
J Biol Chem; 2015 Oct; 290(41):24875-90. PubMed ID: 26304117
[TBL] [Abstract][Full Text] [Related]
4. Probing the caveolin-1 P132L mutant: critical insights into its oligomeric behavior and structure.
Rieth MD; Lee J; Glover KJ
Biochemistry; 2012 May; 51(18):3911-8. PubMed ID: 22506673
[TBL] [Abstract][Full Text] [Related]
5. Structural characterization of the caveolin scaffolding domain in association with cholesterol-rich membranes.
Hoop CL; Sivanandam VN; Kodali R; Srnec MN; van der Wel PC
Biochemistry; 2012 Jan; 51(1):90-9. PubMed ID: 22142403
[TBL] [Abstract][Full Text] [Related]
6. Expression and characterization of recombinant caveolin. Purification by polyhistidine tagging and cholesterol-dependent incorporation into defined lipid membranes.
Li S; Song KS; Lisanti MP
J Biol Chem; 1996 Jan; 271(1):568-73. PubMed ID: 8550621
[TBL] [Abstract][Full Text] [Related]
7. Single molecule network analysis identifies structural changes to caveolae and scaffolds due to mutation of the caveolin-1 scaffolding domain.
Wong TH; Khater IM; Joshi B; Shahsavari M; Hamarneh G; Nabi IR
Sci Rep; 2021 Apr; 11(1):7810. PubMed ID: 33833286
[TBL] [Abstract][Full Text] [Related]
8. Scaffolds and the scaffolding domain: an alternative paradigm for caveolin-1 signaling.
Lim JE; Bernatchez P; Nabi IR
Biochem Soc Trans; 2024 Apr; 52(2):947-959. PubMed ID: 38526159
[TBL] [Abstract][Full Text] [Related]
9. The transmembrane domain of caveolin-1 exhibits a helix-break-helix structure.
Lee J; Glover KJ
Biochim Biophys Acta; 2012 May; 1818(5):1158-64. PubMed ID: 22240009
[TBL] [Abstract][Full Text] [Related]
10. Caveolin-1 Scaffolding Domain Peptides Alleviate Liver Fibrosis by Inhibiting TGF-β1/Smad Signaling in Mice.
Lu J; Zhang J; Wang Y; Sun Q
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29891777
[TBL] [Abstract][Full Text] [Related]
11. Differential impact of caveolae and caveolin-1 scaffolds on the membrane raft proteome.
Zheng YZ; Boscher C; Inder KL; Fairbank M; Loo D; Hill MM; Nabi IR; Foster LJ
Mol Cell Proteomics; 2011 Oct; 10(10):M110.007146. PubMed ID: 21753190
[TBL] [Abstract][Full Text] [Related]
12. Biallelic CAV1 null variants induce congenital generalized lipodystrophy with achalasia.
Karhan AN; Zammouri J; Auclair M; Capel E; Apaydin FD; Ates F; Verpont MC; Magré J; Fève B; Lascols O; Usta Y; Jéru I; Vigouroux C
Eur J Endocrinol; 2021 Nov; 185(6):841-854. PubMed ID: 34643546
[TBL] [Abstract][Full Text] [Related]
13. Reconstitution of full-length human caveolin-1 into phospholipid bicelles: Validation by analytical ultracentrifugation.
Rieth MD; Root KT; Glover KJ
Biophys Chem; 2020 Apr; 259():106339. PubMed ID: 32145579
[TBL] [Abstract][Full Text] [Related]
14. Characterization of a caveolin-1 mutation associated with both pulmonary arterial hypertension and congenital generalized lipodystrophy.
Han B; Copeland CA; Kawano Y; Rosenzweig EB; Austin ED; Shahmirzadi L; Tang S; Raghunathan K; Chung WK; Kenworthy AK
Traffic; 2016 Dec; 17(12):1297-1312. PubMed ID: 27717241
[TBL] [Abstract][Full Text] [Related]
15. Model for the architecture of caveolae based on a flexible, net-like assembly of Cavin1 and Caveolin discs.
Stoeber M; Schellenberger P; Siebert CA; Leyrat C; Helenius A; Grünewald K
Proc Natl Acad Sci U S A; 2016 Dec; 113(50):E8069-E8078. PubMed ID: 27834731
[TBL] [Abstract][Full Text] [Related]
16. Role of the membrane interface on the conformation of the caveolin scaffolding domain: a CD and NMR study.
Le Lan C; Neumann JM; Jamin N
FEBS Lett; 2006 Oct; 580(22):5301-5. PubMed ID: 16979631
[TBL] [Abstract][Full Text] [Related]
17. Simvastatin reduces plasma membrane caveolae and caveolin-1 in uterine leiomyomas.
Afrin S; El Sabeh M; Miyashita-Ishiwata M; Charewycz N; Singh B; Borahay MA
Life Sci; 2022 Sep; 304():120708. PubMed ID: 35705139
[TBL] [Abstract][Full Text] [Related]
18. Interaction of peptides spanning the transmembrane domain of caveolin-1 with model membranes.
Lokappa SB; Nagaraj R
J Pept Sci; 2012 Nov; 18(11):696-703. PubMed ID: 23027578
[TBL] [Abstract][Full Text] [Related]
19. Tagging strategies strongly affect the fate of overexpressed caveolin-1.
Han B; Tiwari A; Kenworthy AK
Traffic; 2015 Apr; 16(4):417-38. PubMed ID: 25639341
[TBL] [Abstract][Full Text] [Related]
20. Caveolin-1 interacts directly with dynamin-2.
Yao Q; Chen J; Cao H; Orth JD; McCaffery JM; Stan RV; McNiven MA
J Mol Biol; 2005 Apr; 348(2):491-501. PubMed ID: 15811383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
